Publications by authors named "Patrick Behrendt"

Claim this Profile
D
Design and Analysis of Novel HEV Vaccine Variants and Evaluation of Two Selected Candidates in a Porcine Infection Model.
Isabella Hrabal, Elmira Aliabadi, Saskia Weber, George Liam Ssebyatika, Thomas Krey, Patrick Behrendt

Liver Int· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extrahepatic Replication and Genomic Signatures of the Hepatitis E Virus in the Kidney.
Avista Wahid, Nele Meyer, Christine Wundes, Lucas Hüffner, Saskia Janshoff, Patrick Behrendt

Liver Int· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Therapeutic treatment of hepatitis E virus infection in pigs with a neutralizing monoclonal antibody.
Isabella Hrabal, Elmira Aliabadi, Sven Reiche, Saskia Weber, Cora M Holicki, Patrick Behrendt

Sci Rep· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fatal outcome of erythropoietic protoporphyria with advanced liver disease.
Richard Taubert, Mohammad Kabbani, Stefanie Walter, Lilia Goudeva, Björn Hartleben, Patrick Behrendt

Clin Res Hepatol Gastroenterol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring of hepatitis E virus infection and replication by functional tagging of the ORF2 protein.
Maliki Ankavay, Nathalie Da Silva, Angela Pollán, Noémie Oechslin, Katja Dinkelborg, Patrick Behrendt

JHEP Rep· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic treatment of hepatitis E virus infection in pigs with a neutralizing monoclonal antibody.
Isabella Hrabal, Elmira Aliabadi, Sven Reiche, Saskia Weber, Cora M Holicki, Patrick Behrendt

Sci Rep· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Broadly neutralizing antibodies isolated from HEV convalescents confer protective effects in human liver-chimeric mice.
George Ssebyatika, Katja Dinkelborg, Luisa J Ströh, Florian Hinte, Laura Corneillie, Patrick Behrendt

Nat Commun· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic determinants of host- and virus-derived insertions for hepatitis E virus replication.
Michael Hermann Wißing, Toni Luise Meister, Maximilian Klaus Nocke, André Gömer, Mejrema Masovic, Patrick Behrendt

Nat Commun· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunisation of pigs with recombinant HEV vaccines does not protect from infection with HEV genotype 3.
Lisa Dähnert, Elmira Aliabadi, Christine Fast, Isabella Hrabal, Charlotte Schröder, Patrick Behrendt

One Health· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic evolution of the sofosbuvir-associated variant A1343V in HEV-infected patients under concomitant sofosbuvir-ribavirin treatment.
André Gömer, Katja Dinkelborg, Mara Klöhn, Michelle Jagst, Michael Hermann Wißing, Patrick Behrendt

JHEP Rep· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emergence of resistance-associated variants during sofosbuvir treatment in chronically infected hepatitis E patients.
André Gömer, Mara Klöhn, Michelle Jagst, Maximilian K Nocke, Sven Pischke, Patrick Behrendt

Hepatology· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced monitoring and detection of recent genotype 3 hepatitis E virus infection through urine antigen testing.
Yannick Stahl, Iyad Kabar, Hauke Heinzow, Benjamin Maasoumy, Birgit Bremer, Patrick Behrendt

Emerg Microbes Infect· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
Janus kinase-inhibition modulates hepatitis E virus infection.
Volker Kinast, Ioana Andreica, Gerrit Ahrenstorf, André Gömer, Carina Elsner, Patrick Behrendt

Antiviral Res· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EGF receptor modulates HEV entry in human hepatocytes.
Jil A Schrader, Thomas L Burkard, Yannick Brüggemann, André Gömer, Toni L Meister, Patrick Behrendt

Hepatology· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urine: a place where HEV cannot hide!
Patrick Behrendt, Jérôme Gouttenoire

Hepatology· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of CT contrast medium is not associated with an increased risk for acute kidney injury in patients with decompensated cirrhosis.
Tammo L Tergast, Benjamin Schulte, Marie Griemsmann, Julia Kahlhöfer, Petra Dörge, Patrick Behrendt

Aliment Pharmacol Ther· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis E virus is effectively inactivated by methylene blue plus light treatment.
Ute Gravemann, Michael Engelmann, Volker Kinast, Thomas Burkard, Patrick Behrendt

Transfusion· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metamizole-Associated Risks in Decompensated Hepatic Cirrhosis.
Benjamin Schulte, Tammo L Tergast, Marie Griemsmann, Denise Menti, Neslihan Deveci, Patrick Behrendt

Dtsch Arztebl Int· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T-cell driven allergic cutaneous reaction complicating treatment of hepatitis delta virus infection with bulevirtide.
Patrick Behrendt, Stephan Traidl, Klaus Hans Wolfgang Böker, Heiner Wedemeyer, Katja Deterding

Liver Int· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis E virus is highly resistant to alcohol-based disinfectants.
Patrick Behrendt, Martina Friesland, Jan-Erik Wißmann, Volker Kinast, Yannick Stahl

J Hepatol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Human Liver-Expressed Lectin CD302 Restricts Hepatitis C Virus Infection.
Birthe Reinecke, Nicola Frericks, Chris Lauber, Katja Dinkelborg, Alina Matthaei, Patrick Behrendt

J Virol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Viral Interference of Hepatitis C and E Virus Replication in Novel Experimental Co-Infection Systems.
Thomas Burkard, Nora Proske, Kathrin Resner, Laura Collignon, Leonard Knegendorf, Patrick Behrendt

Cells· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Vaccines against hepatitis E virus: state of development].
Patrick Behrendt, Heiner Wedemeyer

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of transfusion-transmitted hepatitis E virus infection from pool-tested platelets and plasma.
Anne K Cordes, Lilia Goudeva, Marc Lütgehetmann, Jürgen J Wenzel, Patrick Behrendt

J Hepatol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantification of polyreactive immunoglobulin G facilitates the diagnosis of autoimmune hepatitis.
Richard Taubert, Bastian Engel, Jana Diestelhorst, Katharina L Hupa-Breier, Patrick Behrendt

Hepatology· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis